Postpartum Hemorrhage Market Devices Size, Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Italy, Spain, France, China, India, Japan, Australia, Malaysia, Thailand, Indonesia, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
Report ID: GMI1885
Postpartum Hemorrhage Devices Market size will witness significant growth from 2017 to 2024.
Growing pregnancy complications such as multiple pregnancies, upturned uterus and large size of the baby will drive the postpartum hemorrhage (PPH) devices market. Improvement in health care for women during childbirth to prevent and treat PPH will further rise the demand for the PPH products. It is the foremost cause of maternal mortality in low-income nations and the key cause of approximately one quarter of all maternal deceases globally.
Rising cases of PPH around the world, increasing healthcare investment taken up by multiple governments, along with the gradually increasing education programs and awareness towards the complications caused will boost the industry growth. Technological developments such as competency of the devices to soothe the condition of the patient until perpetual treatment is provided and innovative testing methods will drive the business.
The obstetric-gynecologic specialized manual instrument regulation of FDA controls the postpartum hemorrhage device market. The products are classified as Class II devices, by the regulatory bodies. Regulations address the general controls counting necessities for annual registration, listing of devices, decent manufacturing practice, labeling and prohibitions against adulteration and misbranding. Medi?Cal FFS reimburses maternity care including prenatal care, delivery, and instant postpartum care in U.S.
Based on product, the industry is categorized into Non-Pneumatic Anti-Shock Garment (NASG), Uniject prefilled injection system, Uterine Balloon Tamponade (Condom Catheters, Foley Catheter, BT-Cath balloon, Bakri balloon tamponade, Rusch balloon). According to the WHO, obstetrics hemorrhage accounts for 127,000 deaths per annum globally and is the foremost cause of maternal death. National statistics propose that around 8% of these deaths are caused by PPH. Non-Pneumatic Anti-Shock Garment leads the overall industry revenue by offering cost effectiveness, ease and lower pressure to the body. Simplicity of the NASG adds to its utility for use in community settings where health care providers have minimal training. Uterine Balloon Tamponade market is likely to grow at a substantial rate over the forecast period owing to effectiveness in management, simple arrangement and minimal adverse effect.
According to American College of Obstetricians and Gynecologists, per year or 1 woman every 4 minutes dies due to PPH. Postpartum hemorrhage is a primary reason of pregnancy-related complications, with an estimate of 2.9% women who give birth in the U.S. will bleed excessively. Presence of leading device providers such as Cook Medical and Becton Dickinson and Company (Carefusion Corp.) in the region will stimulate industry growth.
European postpartum hemorrhage devices market will witness tremendous growth due to existence of population with history of severe PPH, anemia, anticoagulant medication, severe preeclampsia or HELLP syndrome, multiple pregnancy and uterine fibromas. Growing PPH cases coupled with favorable growth opportunities for industry players will drive the demand for grafting.
Improving healthcare infrastructure will increase PPH treatment devices demand in China, India and Japan. Additionally, programs introduced by governments to avoid maternal deaths will also offer opportunities for manufacturers across the region. Increasing frequency of PPH in Asia Pacific region is more likely reflected by the lack of widespread availability of medications used in the active management of the third stage of labor. Lack of skilled caregivers, blood transfusion facilities, and operating competences will fuel the postpartum hemorrhage devices market size in the region.
Increasing prevalence of obstetric hemorrhage due to abruption placenta, retained placenta, uterine atony, uterine rupture and other uterine trauma, rising caesarean section will boost the South African postpartum hemorrhage devices market. Growing presence of APH, CTG abnormalities, multiple gestation and prolonged third stage of labor among Saudi women coupled with government and organizational initiatives for patient education on antenatal care and family planning will also fuel the business growth.
Industry participants in the postpartum hemorrhage devices market include Cook Medical, C. R. Bard, Teleflex, Utah Medical Products, Becton and Dickinson, Bactiguard AB, 3RD Stone Design, Zoex Niasg, Vitality Medical, Inpress Technologies, Program for Appropriate Technology in Health (PATH) and Revmedx. Companies are progressively adopting the strategies of partnerships and technological advancement to expand the product portfolio and increase their market share.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability